Here - American Geriatrics Society

More documents

Recommendations

Info

P OSTER A BSTRACTS While we were not able to find another reported case of SOVT associated with the presence of a lupus anticoagulant, evaluation for hypercoagulation syndromes is probably warranted. A92 Spontaneous Retroperitoneal Bleed Presenting as Right leg pain: Psoas sign. T. Hashim, A. H. Chaudhry. Hospitalist, Highline Medical Center, Burien, WA. We report case of 88year old man with past medical history of atrial fibrillation on anticoagulation with Coumadin for chronic atrial fibrillation. Patient presented to our emergency room with 1 day history of right leg pain and inability to walk secondary to severe pain and leg weakness. Patient denied any trauma. The pain was in right groin which was made worse with extension of the hip and was relieved with hip flexion. All other review of systems were negative. His medical problems included diabetes, hypertension and history of CHF.His home medications included Coumadin, Lisinopril, simvastatin and Carvidelol. On physical examination, his blood pressure was 122/65 heart rate 110/min irregular, respiratory rate 22 /min and temperature of 98.7F. His cardio-pulmonary exam was unremarkable. Abdominal exam was benign. Patient however was constantly keeping his right thigh flexed. When patient was turned on his left side and an attempt was made to extend his right leg at the thigh; it resulted in severe pain (positive psoas sign). He also had sensory loss on the anterior upper thigh and also has significant weakness of the right Quadriceps Femoris Muscle. Laboratory data showed hematocrit of 28 which was a drop from his baseline hematocrit of 35. The INR was 4.6 and rest of the chemistry panel was with in normal limits. A CT scan of the abdomen and pelvis without contrast showed huge 13cmx5cmx6.5cm complex fluid collection close to the right iliacus muscle consistent with retroperitoneal bleed. Patient was admitted to ICU for close monitoring. He was transfused 4 units of Fresh frozen plasma along with 2 units of PRBCS and 10mg of IV vitamin K. Surgery recommended conservative management and complete reversal of anticoagulation and frequent hemoglobin checks. Over the next couple of days the patient’s condition improved and his hematocrit stabilized. On the 5th day of hospitalization, patient was discharged home with home health for physical therapy. Conclusion: Retroperitoneal bleed is a Known complication of anticoagulation which usually presents with abdominal pain and back pain. However, sometimes it presents as isolated Psoas sign. Clinicians taking care of patients on anticoagulation should have low threshold for imaging the abdomen (CT or MRI) for patient who present with groin pain or leg pain. A93 The Functional Performance Predictors of Adverse Health Outcomes in Community-Dwelling Older Adults: A preliminary study. T. J. Tseng, 1 P. S. Lin, 1 H. S. Cheng, 2 B. H. Gi. 1 1. Department of Physical Therapy, Graduate Institute of Rehabilitation Science, Chang Gung University, Taoyuan, Taiwan; 2. Internal Medicine, Chang Gung Memorial Hospital, LinKou Branch, Taoyuan, Taiwan. Background and Purpose: The number of older adults keeps increasing in Taiwan. “Frailty” is a newly defined syndrome, the declined physiologic reserve capacities will make older people highly vulnerable to adverse health outcomes, such as hospitalization and mortality. Finding predictors is one of the solutions to prevent or defer those adverse health outcomes. There are two purposes of this study: (1) To examine the differences of the occurrence of the adverse health outcomes in different levels of frailty for 2-year period. (2) To examine the functional performance predictors of older adults’ adverse health outcomes after 2-year period. Method: A convenient sample of 337 older adults, aged 65 years and older, living in the community participated in this study. The baseline evaluation included demographic and health status, functional tests, mental and depressive status. The subjects will be followed up annually and finally, medical record confirms of the occurrence of adverse health outcomes, including hospitalization, emergency visit, and fall. Results: Among the 337 enrolled, 96 of whom were “non-frail”, 191 were “pre-frail”, and 50 were “frail”. Results of preliminary analyses showed, at baseline, the three groups were significantly different in height, weight, comorbidity, GDS, MMSE and all functional tests. The frail older adults have significantly higher percentage of falls (X2= 13.305, p=0.01). The 5-meter gait speed test, functional reach (FR) and 6-min walking test (6 MWT) were the tests that could significantly predict older adults’ hospitalization, emergency visit and falls 2 years later, respectively. Conclusion: The 5-meter gait speed test, FR and 6 MWT were recommended for use to identify community-dwelling older adults who are at risk of future adverse health outcomes. A94 Older Minority Persons Living with HIV/AIDS (PLWHA) The Influence of Social Support on Willingness to Participate in HIV Clinical Trials. R. Arakawa, 1,2 G. Corbie-Smith. 2,3 1. University of Hawaii John A Burns School of Medicine, Honolulu, HI; 2. The Program on Health Disparities Cecil G. Sheps Center for Health Services Research, The University of North Carolina Chapel Hill, Chapel Hill, NC; 3. School of Medicine, The University of North Carolina Chapel Hill, Chapel Hill, NC. Background: Racial and ethnic minorities are disproportionately affected by the AIDS epidemic, yet have been underrepresented in HIV research, including clinical trials. Older adults are increasingly infected, and the population over 50 years old living with AIDS is expected to grow. The unique experience of being an older minority person living with HIV/AIDS (PLWHA), in the context of clinical trial participation, is poorly understood. This study looked for age-related differences in willingness to participate in a clinical trial and specific facilitators of participation. Methods: A cross-sectional, stratified analysis of baseline survey data was conducted as an aspect of Project EAST (Education and Access to Services and Testing), a community-based research project devoted to increasing rural minority participation in research in North Carolina. Textual data from interviews with PLWHA was queried for qualitative support of the findings. Results: Age was not associated with willingness to participate (WTP), and study participants demonstrated a high level of baseline willingness. Older age was associated with high levels of perceived social support from church & religious faith, but lower levels of perceived support from friends. Older participants had lower perceived pressure from their doctors to participate, but most believed their doctor would support their decision to enroll. Both age groups received a higher frequency of support from other resources, including their spouse/partner and other family. Discussion: This study provides no empiric basis for excluding older minority PLWHA from clinical trials research. The high baseline willingness demonstrated by the survey participants is encouraging, but social desirability should be examined as a possible con- S48 AGS 2012 ANNUAL MEETING
P OSTER A BSTRACTS founder. Future efforts to maintain participation should include engagement of faith leaders and doctors to lead discussions about HIV. Additionally, peer-lead interventions to increase knowledge amongst friends may increase subsistence-type support associated with better engagement in care. A95 Encore Presentation Hypertension Control in all Age Groups – a VA 10 Year Multicenter Analysis. R. Fletcher, 1,3 V. Papademetriou, 1 R. Kheirbek, 1,2 R. Amdur, 1,2 C. Faselis, 1,2 R. Jones. 1 1. Veterans Affairs Medical Center, Washington DC, DC; 2. George Washington University Medical Center, Washington DC, DC; 3. Georgetown University Medical Center, Washington DC, DC. Introduction: While the benefits of blood pressure (BP) control are well known, BP control is rarely studied in large populations. Elderly patients have been considered difficult to control. We reviewed blood pressure control in a large cohort of VA patients. Methods: From September 2000 to August 2010, we assessed BP control in 582,851 hypertensive patients from 15 VA hospitals in various geographic locations around the United States. Patients were divided in 4 groups based on age: G1:
Page 1:
Dear Annual Meeting Attendee: The A
Page 8 and 9: P APER A BSTRACTS the National Deat
Page 10 and 11: P APER A BSTRACTS two counts were u
Page 12 and 13: P APER A BSTRACTS management in col
Page 14 and 15: P APER A BSTRACTS control collagen
Page 16 and 17: P APER A BSTRACTS creating a barrie
Page 18 and 19: P APER A BSTRACTS Conclusion: This
Page 20 and 21: P APER A BSTRACTS rates for CRs wer
Page 22 and 23: P APER A BSTRACTS each definition
Page 24 and 25: P OSTER A BSTRACTS been ruled out.
Page 26 and 27: P OSTER A BSTRACTS Discussion: Angi
Page 28 and 29: P OSTER A BSTRACTS calcitriol via 1
Page 30 and 31: P OSTER A BSTRACTS ii J Clin Micrbi
Page 32 and 33: P OSTER A BSTRACTS is on the rise.
Page 34 and 35: P OSTER A BSTRACTS edema (60%), and
Page 36 and 37: P OSTER A BSTRACTS categories based
Page 38 and 39: P OSTER A BSTRACTS Methods: A longi
Page 40 and 41: P OSTER A BSTRACTS Design. CaMos is
Page 42 and 43: P OSTER A BSTRACTS incidents (64%)
Page 44 and 45: P OSTER A BSTRACTS TNF-R1 levels we
Page 46 and 47: P OSTER A BSTRACTS curriculum betwe
Page 48 and 49: P OSTER A BSTRACTS A75 Geriatrics a
Page 50 and 51: P OSTER A BSTRACTS Design: Based on
Page 52 and 53: P OSTER A BSTRACTS medicine fellows
Page 56 and 57: P OSTER A BSTRACTS and knowledge pr
Page 58 and 59: P OSTER A BSTRACTS made more eye co
Page 60 and 61: P OSTER A BSTRACTS This study’s p
Page 62 and 63: P OSTER A BSTRACTS that a substanti
Page 64 and 65: P OSTER A BSTRACTS articulate goals
Page 66 and 67: P OSTER A BSTRACTS transitions invo
Page 68 and 69: P OSTER A BSTRACTS findings suggest
Page 70 and 71: P OSTER A BSTRACTS and its sum of b
Page 72 and 73: P OSTER A BSTRACTS NTM infection wa
Page 74 and 75: P OSTER A BSTRACTS death because
Page 76 and 77: P OSTER A BSTRACTS A158 Curved Path
Page 78 and 79: P OSTER A BSTRACTS compared to pati
Page 80 and 81: P OSTER A BSTRACTS Methods: We are
Page 82 and 83: P OSTER A BSTRACTS with only about
Page 84 and 85: P OSTER A BSTRACTS with typical ris
Page 86 and 87: P OSTER A BSTRACTS The aim of this
Page 88 and 89: P OSTER A BSTRACTS B27 Shared Decis
Page 90 and 91: P OSTER A BSTRACTS SES, adiposity a
Page 92 and 93: P OSTER A BSTRACTS care (OR 1.93, 9
Page 94 and 95: P OSTER A BSTRACTS Conclusion: Agin
Page 96 and 97: P OSTER A BSTRACTS B49 Prevalence a
Page 98 and 99: P OSTER A BSTRACTS Conclusions: The
Page 100 and 101: P OSTER A BSTRACTS B61 Losartan inc
Page 102 and 103: P OSTER A BSTRACTS Conclusions Our
Page 104 and 105:
P OSTER A BSTRACTS Significant incr
Page 106 and 107:
P OSTER A BSTRACTS frailty have inc
Page 108 and 109:
P OSTER A BSTRACTS Conclusion: In t
Page 110 and 111:
P OSTER A BSTRACTS BMI=28.4, mean P
Page 112 and 113:
P OSTER A BSTRACTS Each subject’s
Page 114 and 115:
P OSTER A BSTRACTS There is growing
Page 116 and 117:
P OSTER A BSTRACTS variation in uti
Page 118 and 119:
P OSTER A BSTRACTS complex elders s
Page 120 and 121:
P OSTER A BSTRACTS satisfaction wit
Page 122 and 123:
P OSTER A BSTRACTS Methods: The Hon
Page 124 and 125:
P OSTER A BSTRACTS B130 Early Disco
Page 126 and 127:
P OSTER A BSTRACTS IgE antibodies i
Page 128 and 129:
P OSTER A BSTRACTS contribution by
Page 130 and 131:
P OSTER A BSTRACTS The oldest old (
Page 132 and 133:
P OSTER A BSTRACTS B153 Encore Pres
Page 134 and 135:
P OSTER A BSTRACTS B159 Accuracy of
Page 136 and 137:
P OSTER A BSTRACTS GDS and GDS apat
Page 138 and 139:
P OSTER A BSTRACTS status, procedur
Page 140 and 141:
P OSTER A BSTRACTS In this case it
Page 142 and 143:
P OSTER A BSTRACTS the episodes of
Page 144 and 145:
P OSTER A BSTRACTS paralysis is see
Page 146 and 147:
P OSTER A BSTRACTS grip strength ch
Page 148 and 149:
P OSTER A BSTRACTS Discussion/Concl
Page 150 and 151:
P OSTER A BSTRACTS Results: Of 1401
Page 152 and 153:
P OSTER A BSTRACTS Results: Regiona
Page 154 and 155:
P OSTER A BSTRACTS Conclusions: Con
Page 156 and 157:
P OSTER A BSTRACTS 2.47-25.96), and
Page 158 and 159:
P OSTER A BSTRACTS Methods: EMR ACP
Page 160 and 161:
P OSTER A BSTRACTS patient populati
Page 162 and 163:
P OSTER A BSTRACTS C71 Outpatient A
Page 164 and 165:
P OSTER A BSTRACTS IPE are generall
Page 166 and 167:
P OSTER A BSTRACTS the outpatient s
Page 168 and 169:
P OSTER A BSTRACTS 0.03). Age and s
Page 170 and 171:
P OSTER A BSTRACTS C94 Exploring th
Page 172 and 173:
P OSTER A BSTRACTS with the least e
Page 174 and 175:
P OSTER A BSTRACTS physician resist
Page 176 and 177:
P OSTER A BSTRACTS Table 1. Effect
Page 178 and 179:
P OSTER A BSTRACTS C118 Patient and
Page 180 and 181:
P OSTER A BSTRACTS We monitor the t
Page 182 and 183:
P OSTER A BSTRACTS PROGRAM STRUCTUR
Page 184 and 185:
P OSTER A BSTRACTS C135 Encore Pres
Page 186 and 187:
P OSTER A BSTRACTS C141 Contributio
Page 188 and 189:
P OSTER A BSTRACTS nal process can
Page 190 and 191:
P OSTER A BSTRACTS project, we atte
Page 192 and 193:
P OSTER A BSTRACTS Methods: Two hun
Page 194 and 195:
P OSTER A BSTRACTS Case: A 78 year-
Page 196 and 197:
P OSTER A BSTRACTS two synergistic
Page 198 and 199:
P OSTER A BSTRACTS then awoke spont
Page 200 and 201:
P OSTER A BSTRACTS cancer, non mali
Page 202 and 203:
P OSTER A BSTRACTS The diagnosis of
Page 204 and 205:
P OSTER A BSTRACTS D32 Comparison o
Page 206 and 207:
P OSTER A BSTRACTS D38 The burden o
Page 208 and 209:
P OSTER A BSTRACTS rate was 21.9% f
Page 210 and 211:
P OSTER A BSTRACTS D50 A Pilot Stud
Page 212 and 213:
P OSTER A BSTRACTS of the education
Page 214 and 215:
P OSTER A BSTRACTS and geriatrics c
Page 216 and 217:
P OSTER A BSTRACTS Care Surgery, Em
Page 218 and 219:
P OSTER A BSTRACTS survey using the
Page 220 and 221:
P OSTER A BSTRACTS & Go Test, and T
Page 222 and 223:
P OSTER A BSTRACTS binge drinking d
Page 224 and 225:
P OSTER A BSTRACTS The percentages
Page 226 and 227:
P OSTER A BSTRACTS other forms of t
Page 228 and 229:
P OSTER A BSTRACTS D102 Clinician
Page 230 and 231:
P OSTER A BSTRACTS this result repr
Page 232 and 233:
P OSTER A BSTRACTS D114 Fall Reduct
Page 234 and 235:
P OSTER A BSTRACTS D120 Geropsychia
Page 236 and 237:
P OSTER A BSTRACTS In addition to 7
Page 238 and 239:
P OSTER A BSTRACTS D132 Encore Pres
Page 240 and 241:
P OSTER A BSTRACTS Conclusions: The
Page 242 and 243:
P OSTER A BSTRACTS D144 The Use of
Page 244 and 245:
P OSTER A BSTRACTS Methods: Cross-s
Page 246 and 247:
P OSTER A BSTRACTS CONCLUSIONS: The
Page 248 and 249:
P OSTER A BSTRACTS Aggressive treat
Page 250 and 251:
A UTHOR I NDEX Azhar, G . . . . . .
Page 252 and 253:
A UTHOR I NDEX Ceimo, J . . . . . .
Page 254 and 255:
A UTHOR I NDEX Dunn, C M . . . . .
Page 256 and 257:
A UTHOR I NDEX Griebling, T L . . .
Page 258 and 259:
A UTHOR I NDEX Johnson, K . . . . .
Page 260 and 261:
A UTHOR I NDEX Levine, M . . . . .
Page 262 and 263:
A UTHOR I NDEX Mulsant, B . . . . .
Page 264 and 265:
A UTHOR I NDEX Pschirer, J P . . .
Page 266 and 267:
A UTHOR I NDEX Sheppard, K D . . .
Page 268 and 269:
A UTHOR I NDEX Ukritchon, S . . . .
Page 270 and 271:
K EYWORD 25-hydroxyvitamin D . . .
Page 272 and 273:
K EYWORD I NDEX Colorectal cancer s
Page 274 and 275:
K EYWORD I NDEX Geriatric curriculu
Page 276 and 277:
K EYWORD I NDEX Medication discrepa
Page 278 and 279:
K EYWORD I NDEX Race . . . . . . .
Page 280:
This page intentionally left blank
show all

Here - American Geriatrics Society

Create successful ePaper yourself

Delete template?

Save as template?